Peter Stein

3.9k citations
23 papers · 3.1k · 2 hit papers · h-index 14

Impact in

Papers in

Peter Stein

23 papers receiving 3.0k citations

Peter Stein's Hit Papers

Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective 2021 · 180 citations
1800+12+24Years since publication250500750

Peers

Peter Stein
Comparison fields: 5 of 107
  • Endocrinology, Diabetes and Metabolism 1.7k
  • Physiology 641
  • Pharmacology 285
  • Surgery 623
  • Cell Biology 250
Replace Antti Hakkarainen with:
Antti Hakkarainen Finland
Luke Norton United States
Mariella Trovati Italy
Karl F. Hilgers Germany
Lucia Frittitta Italy
Tjerk W.A. de Bruin Netherlands
Brigitte Rigat Canada
Giulio Ceolotto Italy
Hirofumi Hitomi Japan
Kazunori Utsunomiya Japan
Peter Stein relative to Antti Hakkarainen Finland Antti Hakkarainen's profile →
Citations per field
00.5×1.5×1.9×
Antti Hakkarainen · 1×
Citations per year

Countries citing papers authored by Peter Stein

Since Specialization
Citations

This map shows the geographic impact of Peter Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stein more than expected).

Fields of papers citing papers by Peter Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stein. The network helps show where Peter Stein may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Stein Line = papers co-authored together Peter Stein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance Spectroscopy
Hit paper breakdown →
1990990
2 2006432
3 2007430
4 2013280
5 2014222
6 2006218
7
Approval of Aducanumab for Alzheimer Disease—The FDA’s Perspective
Hit paper breakdown →
2021180
8 199089
9 201279
10 201443
11 202026
12 201021
13 202117
14 201813
15 202311
16
Mechanisms of Lung Injury
198511
17 20027
18 20135
19 20183
20 20202

About Peter Stein

Peter Stein is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Statistics and Probability, Surgery and Molecular Biology, having authored 23 papers that have together received 3.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Statistical Methods in Clinical Trials (3 papers), Diabetes Management and Research (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Adipose Tissue and Metabolism (2 papers), Biomedical Ethics and Regulation (2 papers), Medication Adherence and Compliance (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.7k citations), Physiology (641 citations), Pharmacology (285 citations), Surgery (623 citations) and Cell Biology (250 citations). Peter Stein has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Ralph A. DeFronzo, Gerald I. Shulman, Douglas L. Rothman, Robert G. Shulman, Thomas Jue, Kaifeng Lu, Julio Rosenstock, Ronald Brazg, Kjeld Hermansen and Mark Kipnes. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Canadian Journal of Diabetes, Diabetes Obesity and Metabolism, Therapeutic Innovation & Regulatory Science and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact